Showing results (371-380 of 664) with videos related to
Sort By:
Pageof 67
Cancer Chemotherapy and Pharmacology|January 17, 2025
A phase I study of MLN4924 and belinostat in relapsed/refractory acute myeloid leukemia or myelodysplastic syndromeKeri R Maher, Danielle Shafer, Dale Schaar, et al.Transfusion|December 12, 2025
D-Alloantibody Titration Assessment Study: In Search of a Common Antibody Titration Platform-A BEST Collaborative StudyFatima A Aldarweesh, Rim Abdallah, Ingrid Perez Alvarez, et al.The Journal of Organic Chemistry|March 25, 2005
Photoenolization of 2-(2-methyl benzoyl) benzoic acid, methyl ester: effect of E photoenol lifetime on the photochemistryArmands Konosonoks, P John Wright, Meng-Lin Tsao, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2004
Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology GroupHoward Hochster, Elizabeth R Plimack, Carolyn D Runowicz, et al.BMC Health Services Research|November 30, 2016
The patient reporting and action for a safe environment (PRASE) intervention: a feasibility studyJane K O'Hara, Rebecca J Lawton, Gerry Armitage, et al.International Journal of Environmental Research and Public Health|September 20, 2013
Natural exposure of horses to mosquito-borne flaviviruses in south-east Queensland, AustraliaNatalie A Prow, Cindy S E Tan, Wenqi Wang, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 12, 2021
Respiratory syncytial virus in young children: community cohort study integrating serological surveys, questionnaire and electronic health records, Born in Bradford cohort, England, 2008 to 2013Ania Zylbersztejn, Lucy Pembrey, Harvey Goldstein, et al.Journal of the National Comprehensive Cancer Network : JNCCN|October 2, 2009
Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-IIOwen O'Connor, John Wright, Craig H Moskowitz, et al.Cancer Chemotherapy and Pharmacology|May 13, 2014
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanomaDevalingam Mahalingam, Laeeq Malik, Muralidhar Beeram, et al.The Australian Journal of Rural Health|November 7, 2024
The revised remote area nurse model of consultationSue Lenthall, Sabina Knight, Colin Watson, et al.Pageof 67